Skip to content

Home Map The News Technology Politics Business Sports Entertainment Science Health World

Global AI-Powered News Intelligence. Real-time headlines, mapped by continent and country, from news sources worldwide.

Powered by AI

Navigate

Home
Map The News
About
Sources & methodology
Sources & methodology
Search

Sections

Technology
Politics
Business
Sports
Entertainment
Science

More

Privacy
Contact
Sitemap
Robots

© 2026 newsGlobal. All rights reserved.

Headlines refresh every 10 minutes.

Home Map Search Topics About

Home / Business

Business

Bloomberg

BusinessBloomberg·Sep 2, 2026·1 min read

Boehringer Signs Deal for Owkin AI, Joining Astra and Sanofi

Boehringer Ingelheim GmbH agreed to use Owkin’s artificial-intelligence model to help discover new oncology and immunology medicines.

View original source — Bloomberg ↗

ShareShare on X Share on Facebook

Related stories

Owkin signs AI drug discovery deal with Boehringer for cancer, immunology

BusinessSep 2, 2026 · 1 min

Owkin signs AI drug discovery deal with Boehringer for cancer, immunology

Meta AI Chief Sees Opportunity in Models’ Giving Health Advice

HealthJun 5, 2026 · 1 min

Meta AI Chief Sees Opportunity in Models’ Giving Health Advice

TechnologyJun 9, 2026 · 1 min

ChatGPT maker OpenAI files for IPO, joining Anthropic and SpaceX in race to go public

Which company could become the Chinese Pfizer? Here are analysts’ top picks

South China Morning Post

WorldJun 7, 2026 · 1 min

Which company could become the Chinese Pfizer? Here are analysts’ top picks

South China Morning Post